Past Clinical Biomarkers & Diagnostics Events

November 2022

The Guardant Health Engager is an exclusive 2-hour networking event designed for BioPharma Directors, Heads & VPs working in the Translational Medicine and Companion Diagnostics space looking to stay ahead of the curve and develop the next generation of cancer therapeutics.

This exclusive Labcorp Oncology Engager will be focusing on the benefits of utilizing liquid biopsy alone or in conjunction with tissue-based genomic testing to empower clinical trial optimization and, ultimately, access to better treatment options for patients through precision medicine.

The Agilent Technologies Engager will be focusing on the utilization of liquid biopsies in therapy selection, detection of biomarkers that cause resistance and continued response monitoring and how this can be used to advance novel biomarker discovery.

The Roche PHCS News & Brews comes at a crucial moment in time. Exclusively designed for top decision-makers in biopharma and academia working in the biomarker discovery, digital pathology, and precision medicine space, this 2-hour networking meeting will discuss how to maximize the success of biomarker-driven trials and indulge in high-level discussions to strategize the implementation of these technologies to help you improve your ability to treat disease and identify drug targets in immuno-oncology.

The PathAI Engager is an exclusive event designed to navigate through the latest advancements in AI-powered NASH assessment and discover how biopharma companies are taking this approach in their clinical trials for more reproducible results, as well as unlocking novel insights in translational research.

September 2022

The Roche PHCS News & Brews is an exclusive event designed to bring together biopharma Directors, Heads & VPs working in the Computational Pathology & Artificial Intelligence (AI) space, to discuss and review the latest trends in the use of digital pathology and how it can maximise the success of biomarker driven trials. 

This Foundation Medicine Engager has been exclusively designed for Precision Medicine biopharma leaders to review best practices for Comprehensive Genomic Profiling (CGP) and highlight how it can help you advance confidently through the clinical development chain in a simpler, quicker, and more reliable way.

This was your opportunity to discover the latest biomarker and CGP strategies to advance personalised treatment decisions, as well as explore the importance of a strong global partnership to enhance your drug development journey.

The Roche PHCS News & Brews is an exclusive event designed to bring together biopharma Directors, Heads & VPs working in the Computational Pathology & Artificial Intelligence (AI) space, to discuss and review the latest trends in the use of digital pathology and how it can maximise the success of biomarker driven trials. 

August 2022

The Quest Diagnostics Engager is an exclusive event designed to provide biopharma Directors, Heads and VPs working in Translational Research, Precision Medicine and Clinical Research with the opportunity to discuss and review key strategies and best practices for a successful CDx launch from development all the way to commercialization.

June 2022

This is an exclusive event created to provide senior pharma leaders with the opportunity to hear from fellow pharma stakeholders and researchers on how they are using circulating tumor DNA (ctDNA) to optimize and accelerate oncology therapeutic development.

Join us for an insightful panel discussion among pharma Directors, VPs and Functional Heads within the translational, clinical development, and diagnostics arenas, and connect over a few appetizers and drinks!

This Guardant Health Engager is an exclusive, limited-attendance event that will review and discuss the latest trends in the use of breast oncology trials and RWE in precision oncology research covering R&D, and post-market applications.

Join us to delve into the value of incorporating patient and HCP-level data in clinical and commercial strategies, and discover how to optimize clinical trial design and commercial effectiveness using RWE.